Q&A
Data metrics for tracking program outcomes and community impact
0:51:15
ยท
86 sec
Council Member Linda Lee asks for more detail on the data metrics being collected to track reductions in overdoses, increased treatment uptake, and improvements in community well-being. Dr. Rebecca Linn-Walton explains the various metrics and approaches used to measure program effectiveness.
- Metrics include the number of harm reduction materials distributed, number of kits handed out, and number of engagements in care and referrals
- They track whether people are engaging in the care they're referred to
- At the community level, they monitor whether overdose numbers are decreasing
- When numbers don't decrease, they investigate whether they're reaching everyone experiencing overdoses
- They layer data from different sources, such as Relay data from hospitals, to get a comprehensive picture
Linda Lee
0:51:15
I have another I'll circle around later with that question.
0:51:20
And then yeah.
0:51:23
Oh, yeah.
0:51:23
No.
0:51:23
Not about that.
0:51:24
Sorry.
0:51:24
A different one.
0:51:27
And in terms of can you go a little bit more into detail?
0:51:29
I know you started, going into it a little bit, but in terms of the the outcomes and evaluation piece, what are some of the, data metrics you're collecting to track the reductions in overdoses, increased treatment uptake, or improvements in community well-being?
0:51:47
Because I know you've alluded to some of the outcomes, but then how is it that you're what are the metrics you're using to collect that data?
Dr. Rebecca Linn- Walton
0:51:53
Yeah.
0:51:53
So, and just to clarify, were you asking about the OPCs or the OOPPs?
Linda Lee
0:51:58
No.
0:51:58
Just in terms of, the, for example, the syringe service expansions, the public health campaigns, all of that stuff.
Mercedes Narcisse
0:52:06
Yeah.
Dr. Rebecca Linn- Walton
0:52:06
Yeah.
0:52:07
So we're looking at the number of, harm reduction materials that are handed out, the number of kits handed out, and then the number of engagements in care and referrals and whether people are engaging in that care as well.
0:52:18
So it's looking at a typical program, you wanna see whether it's effective in reducing those rates, and then we're looking at the community level.
0:52:26
Are we seeing the numbers go down?
0:52:27
And when we're not, is it that we're not meeting everyone who's experiencing overdoses?
0:52:33
So then we wanna layer on, for example, the relay data at the hospitals because not everyone is engaged in a program when they're at the point of having overdosed.